Investors & Media

Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.

Latest News

Medigene participates at upcoming conferences


Medigene reports on Annual General Meeting 2021


Medigene presents compelling in vivo data for use of PD1-41BB-enhanced TCR-T cells against solid tumors


The Medigene Share

The Medigene share MDG1 (ISIN:DE000A1X3W00 ) is listed at the Frankfurt Stock Exchange since June 2000. 

show medigene share


12 Aug 2021

6-Month Report 2021

31 Aug - 02 Sep 2021

CAR-TCR Summit 2021

13 - 15 Sep 2021

H.C. Wainwright 23rd Annual Global Investment Conference

20 - 24 Sep 2021

10th Baader Investment Conference

11 Nov 2021

Quarterly Statement Q3 2021

16 - 18 Nov 2021

12th Annual Jefferies Global Healthcare Conference

16 - 18 Nov 2021

Cell Immunotherapies for Solid Tumors Summit

04 - 06 May 2022

Advanced Therapies

07 - 08 Sep 2022

Stifel London Cross Sector Insight Conference

Corporate Governance

Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.

read more

press photos

Laboratory work

DownLoad (9 MB)

Laboratory work (6)

Cell culture work

DownLoad (4 MB)

Laboratory work (7)

Cell sorting

DownLoad (353 KB)

Contact person

Dr. Anna Niedl
Vice President Investor Relations & Corporate Communications
Phone: +49 89 2000 3333 01
Fax: +49 89 2000 33 2920